Amanote Research
Register
Sign In
Pmh65 - Persistence With Selective Serotonin (Norepinephrine) Reuptake Inhibitor Therapy in Germany
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1700
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
E.J. Kap
K. Kostev
Publisher
Elsevier BV
Related search
Pmh16 - The Prescription Patterns of Selective Serotonin (Norepinephrine) Reuptake Inhibitors in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effects of the Selective Norepinephrine Reuptake Inhibitor Reboxetine on Norepinephrine and Serotonin Transmission in the Rat Hippocampus
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Sibutramine, a Serotonin–norepinephrine Reuptake Inhibitor, Causes Fibrosis in Rats
Environmental Toxicology and Pharmacology
Mutagenesis
Toxicology
Health
Pharmacology
Medicine
Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door?
Journal of Biomedical Science and Engineering
Selective Serotonin Reuptake Inhibitor–Induced Spermatorrhea in 2 Patients
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Deciding Which Selective Serotonin Reuptake Inhibitor to Prescribe
BMJ
Selective Serotonin Reuptake Inhibitor Add-On Therapy for the Negative Symptoms of Schizophrenia
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Selective Serotonin Reuptake Inhibitor Drug Interactions in Patients Receiving Statins
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Treatment of Temporomandibular Pain With the Selective Serotonin Reuptake Inhibitor Paroxetine
The Primary Care Companion to The Journal of Clinical Psychiatry